Systemic lupus erythematosus in pediatric patients: Pulmonary manifestations

Jonathan G Palafox-Flores1, Omar E Valencia-Ledezma2, Guillermo Vargas-López3

  • 1Pediatric Pneumology Unit, Hospital Regional de Alta Especialidad de Ixtapaluca, Mexico.

Respiratory Medicine
|November 5, 2023
PubMed

Insights

Pulmonary manifestations in pediatric Systemic Lupus Erythematosus (SLE) are diverse, with pleurisy being most common. This study clarifies these lung issues in children, improving understanding beyond adult data.

Area of Science:

  • Pediatric Rheumatology
  • Pulmonology
  • Systemic Lupus Erythematosus (SLE)

Background:

  • Pulmonary involvement in pediatric Systemic Lupus Erythematosus (SLE) is understudied.
  • Adult SLE pulmonary manifestations are often inaccurately extrapolated to pediatric cases.
  • Limited data exists on the specific spectrum of lung diseases in children with SLE.

Purpose of the Study:

  • To identify and characterize pulmonary manifestations in pediatric patients with SLE.
  • To analyze associated symptoms and antibody levels in this population.
  • To provide a clearer understanding of SLE's impact on pediatric lungs.

Main Methods:

  • Retrospective review of 228 patient files from Hospital Regional de Alta Especialidad de Ixtapaluca.
  • Identification of pulmonary manifestations, symptoms, and antibody levels.
  • Statistical analysis using Chi-square and Mann-Whitney U tests for group comparisons.

Main Results:

  • Pleurisy (14%) was the most frequent pulmonary manifestation.
  • Other identified manifestations included pulmonary hemorrhage (3.9%) and thromboembolism (0.9%).
  • Dyspnea (9.6%) was the primary symptom; pleural effusion was common in radiographic findings. No significant antibody level differences were noted between groups.

Conclusions:

  • Pleurisy is the predominant pulmonary manifestation in pediatric SLE patients.
  • The spectrum of pulmonary involvement in pediatric SLE is broad and varied.
  • Further research is needed to fully elucidate the diverse presentations and management of lung disease in pediatric SLE.

Related Concept Videos

Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
853
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
7
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
243
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.6K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
246